• 1
    Fuchs V. Who shall live? Health, economics and social choice. New York: Basic Books; 1974.
  • 2
    Williams A. The economic role of “health indicators.” In: Teeling SmithG, ed. Measuring the Social Benefit of Medicine. London, UK: Office of Health Economics; 1983: 63-67.
  • 3
    Davis K. Slowing the growth of health care costs—learning from international experience. N Engl J Med. 2008; 357: 1751-1755.
  • 4
    Fuchs V. The “inconvenient truth” about health care. N Engl J Med. 2008; 357: 1749-1751.
  • 5
    Marmor T, Oberlander J, White J. The Obama administration's options for health care cost control: hope vs. reality. Ann Intern Med. 2009; 150: 485-489.
  • 6
    Ontario Ministry of Finance. Ontario Budget 2008: Chapter I. Available at: Accessed March 2, 2010.
  • 7
    Gafni A, Birch S. Incremental cost-effectiveness ratios (ICERs): the silence of the lambda. Soc Sci Med. 2006; 62: 2091-2100.
  • 8
    Birch S, Gafni A. Information created to evade reality (ICER): things we should not look to for answers. PharmacoEconomics. 2006; 24: 1121-1131.
  • 9
    Birch S, Gafni A. The bigger bang for the buck or bigger bucks for the bang: the fallacy of the cost effectiveness threshold. J Health Serv Res Policy. 2006; 11: 46-51.
  • 10
    Cleary S, McIntyre D. Affordability—the forgotten criterion in health care priority setting. Health Econ. 2009; 18: 373-376.
  • 11
    Gafni A, Birch S. Guidelines for the adoption of new technologies: a prescription for uncontrolled growth in expenditures and how to avoid the problem. Can Med Assoc J. 1993; 148: 913-917.
  • 12
    Sendi P, Gafni A, Birch S. Opportunity cost and uncertainty in the economic evaluation of health care interventions. Health Econ. 2002; 11: 23-31.
  • 13
    Williams A, Cookson R. Equity in health. In: CulyerA, NewhouseJ, eds. Handbook on Heath Economics. Vol. 1B. Amsterdam: North Holland; 2000: 1862-1910.
  • 14
    Vayda E, Deber R. The Canadian health care system: a developmental overview. In: NaylorD, ed. Canadian Health Care and the State. Kingston, ON: McGill-Queens University Press; 1992: 125-140.
  • 15
    Birch S, Gafni A. Economics and the evaluation of health care programs: generalizability of methods and the implications for generalizability of results. Health Policy. 2003; 64: 207-219.
  • 16
    Natarajan MK, Gafni A, Yusuf S. Determining optimal population rates of cardiac catheterization: a phantom alternative. Can Med Assoc J. 2005; 173: 49-52.